Frequency Therapeutics, Inc.
TAZ ACTIVATORS AND WNT AGONISTS FOR TREATING EAR DISORDERS
Last updated:
Abstract:
Provided are compositions and methods comprising a TAZ activator and a Wnt agonist for increasing proliferation of cochlear supporting cells or vestibular supporting cells, and related methods of treating inner ear hearing or balance disorders.
Status:
Application
Type:
Utility
Filling date:
7 Feb 2020
Issue date:
26 May 2022